IMPLANET will hold an Extraordinary General Meeting on November 16, 2023, and announces the implementation of short-term financing of a maximum net amount of €1.0 million in the form of a bond issue

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in implants for orthopedic surgery and the distribution of technological medical equipment, informs its shareholders that an Extraordinary General Meeting will be held at 2 pm CEST on November 16, 2023, at the Company’s head offices (Allée F. Magendie, Technopole Bordeaux Montesquieu, 33650 Martillac, F